The National Institutes of Health (NIH) has ended two clinical trials of potential therapeutics for the novel coronavirus (COVID-19), finding that the two therapeutics were of no use. NIH noted that there were no safety concerns with either therapeutic agent and no indication of harm in the therapeutic group compared to the placebo group. To read the NIH announcement and summary of ending two clinical trials on COVID-19 therapeutics, use the link below.
https://www.nih.gov/news-events/news-releases/nih-sponsored-activ-3-clinical-trial-closes-enrollment-into-two-sub-studies